Is the JAK-STAT Signaling Pathway Involved in the Pathogenesis of Depression?

(1) Background: Only 60–70% of depressed patients respond to standard antidepressant treatments. Hence, it is essential to search for new, effective and safe therapies for unmet clinical needs of treatment-resistant depression (TRD). Agents targeting the components of the JAK-STAT signaling pathway...

Descripción completa

Detalles Bibliográficos
Autores principales: Gałecka, Małgorzata, Szemraj, Janusz, Su, Kuan-Pin, Halaris, Angelos, Maes, Michael, Skiba, Aleksandra, Gałecki, Piotr, Bliźniewska-Kowalska, Katarzyna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999744/
https://www.ncbi.nlm.nih.gov/pubmed/35407663
http://dx.doi.org/10.3390/jcm11072056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999744/
https://www.ncbi.nlm.nih.gov/pubmed/35407663
http://dx.doi.org/10.3390/jcm11072056

Ejemplares similares